Panoramic Investment Advisors LLC Makes New Investment in DaVita Inc. (NYSE:DVA)

Panoramic Investment Advisors LLC acquired a new stake in shares of DaVita Inc. (NYSE:DVA) during the first quarter, HoldingsChannel reports. The fund acquired 1,473 shares of the company’s stock, valued at approximately $203,000.

A number of other large investors have also added to or reduced their stakes in DVA. Vanguard Group Inc. increased its holdings in DaVita by 2.4% during the fourth quarter. Vanguard Group Inc. now owns 6,320,740 shares of the company’s stock valued at $662,161,000 after buying an additional 145,711 shares during the last quarter. Gates Capital Management Inc. grew its holdings in DaVita by 3.1% during the fourth quarter. Gates Capital Management Inc. now owns 905,830 shares of the company’s stock valued at $94,895,000 after purchasing an additional 27,660 shares during the period. 8 Knots Management LLC purchased a new stake in DaVita in the fourth quarter worth about $89,504,000. Lazard Asset Management LLC lifted its position in shares of DaVita by 8.7% during the 3rd quarter. Lazard Asset Management LLC now owns 845,416 shares of the company’s stock valued at $79,916,000 after buying an additional 67,970 shares in the last quarter. Finally, Allianz Asset Management GmbH increased its holdings in DaVita by 63.9% in the 4th quarter. Allianz Asset Management GmbH now owns 548,642 shares of the company’s stock worth $57,476,000 after acquiring an additional 213,992 shares in the last quarter. Institutional investors own 90.12% of the company’s stock.

DaVita Price Performance

DVA stock traded down $0.60 during trading on Tuesday, hitting $138.01. 128,489 shares of the company’s stock traded hands, compared to its average volume of 869,965. The business has a fifty day simple moving average of $139.83 and a 200 day simple moving average of $127.09. The company has a debt-to-equity ratio of 7.95, a quick ratio of 1.37 and a current ratio of 1.43. The stock has a market capitalization of $12.10 billion, a price-to-earnings ratio of 15.75, a P/E/G ratio of 1.06 and a beta of 0.96. DaVita Inc. has a 52 week low of $71.51 and a 52 week high of $147.93.

DaVita (NYSE:DVA) last issued its quarterly earnings data on Thursday, May 2nd. The company reported $2.38 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.95 by $0.43. The business had revenue of $3.07 billion for the quarter, compared to the consensus estimate of $3.03 billion. DaVita had a return on equity of 68.52% and a net margin of 6.61%. The company’s quarterly revenue was up 6.9% compared to the same quarter last year. During the same period in the prior year, the business posted $1.58 earnings per share. As a group, research analysts expect that DaVita Inc. will post 9.62 EPS for the current fiscal year.

Analyst Ratings Changes

DVA has been the subject of a number of recent analyst reports. Truist Financial upped their price target on shares of DaVita from $135.00 to $150.00 and gave the stock a “hold” rating in a research report on Wednesday, May 15th. Barclays upped their price objective on DaVita from $133.00 to $150.00 and gave the stock an “equal weight” rating in a research note on Monday, May 6th. Finally, StockNews.com downgraded DaVita from a “strong-buy” rating to a “buy” rating in a research note on Saturday, June 8th. Two equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat.com, DaVita currently has a consensus rating of “Moderate Buy” and a consensus target price of $144.67.

Insider Buying and Selling at DaVita

In other DaVita news, Director Barbara J. Desoer sold 5,030 shares of the business’s stock in a transaction that occurred on Friday, May 10th. The stock was sold at an average price of $138.81, for a total transaction of $698,214.30. Following the completion of the transaction, the director now owns 10,954 shares in the company, valued at $1,520,524.74. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 2.00% of the company’s stock.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.